Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun;138(6):1011-7.
doi: 10.1007/s00432-012-1177-3. Epub 2012 Feb 24.

Quantification of ZAP-70 mRNA by real-time PCR is a prognostic factor in chronic lymphocytic leukemia

Yin-Hua Wang  1 , Zhi-Jian Zou, Ling Liu, Li-Na Zhang, Cheng Fang, Dan-Xia Zhu, Lei Fan, Jian-Yong Li, Wei Xu
Affiliations

Quantification of ZAP-70 mRNA by real-time PCR is a prognostic factor in chronic lymphocytic leukemia

Yin-Hua Wang et al. J Cancer Res Clin Oncol. 2012 Jun.

Abstract

Background: Chronic lymphocytic leukemia (CLL) is heterogeneous with respect to prognosis and clinical outcome. Mutational status of immunoglobulin heavy chain variable region (IGHV) appears to be a particularly strong prognostic marker, but it is difficult to perform in a routine clinical laboratory. ζ-chain-associated protein kinase 70 kDa (ZAP-70) protein detected by flow cytometry is a strong surrogate marker of IGHV mutational status; however, it suffers from the lack of standardization.

Methods: We investigated whether ZAP-70 mRNA expression level can be a prognostic factor in CLL. Real-time quantitative polymerase chain reaction was used to analyze ZAP-70 mRNA expression from 102 CLL patients.

Results: The expression of ZAP-70 mRNA was significantly associated with Binet stage (P < 0.001), lactate dehydrogenase (P = 0.003), ZAP-70 protein (P = 0.018), IGHV mutational status (P = 0.038), and cytogenetic abnormality of del(17p13) or del(11q22.3) (P = 0.037) in CLL patients. According to receiver operating characteristic curve analysis for ZAP-70 mRNA and ZAP-70 protein, positive ZAP-70 mRNA (P = 0.006) was an adverse factor in determining the treatment free survival (TFS). In a multivariate Cox analysis of TFS, ZAP-70 mRNA is not ideal as an independent prognostic factor. However, ZAP-70 mRNA was statistically significant in predicting treatment response.

Conclusion: This study demonstrated the value of determination of ZAP-70 mRNA in providing useful prognostic information in CLL patients. However, ZAP-70 mRNA is not an independent prognostic factor.

PubMed Disclaimer

Conflict of interest statement

We declare that we have no conflict of interest.

Figures

Fig. 1
Fig. 1
ROC curve analysis for ZAP-70 mRNA expression level and ZAP-70 protein measured by flow cytometry (AUC = 0.683, P = 0.018); chosen cut-off is indicated by the black arrow
Fig. 2
Fig. 2
Treatment free survival (months) curve of patients with ZAP-70 mRNA-negative and ZAP-70 mRNA-positive
See this image and copyright information in PMC

References

    1. Antic D, Mihaljevic B, Cokic V, Fekete MD, Djurasevic TK, Pavlovic S et al (2011) Patients with early stage chronic lymphocytic leukemia: new risk stratification based on molecular profiling. Leuk Lymphoma 52(7):1394–1397 - DOI - PubMed
    1. Best OG, Ibbotson RE, Parker AE, Davis ZA, Orchard JA, Oscier DG (2006) ZAP-70 by flow cytometry: a comparison of different antibodies, anticoagulants, and methods of analysis. Cytometry B Clin Cytom 70(4):235–241 - PubMed
    1. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J et al (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48(1):198–206 - DOI - PubMed
    1. Catherwood MA, Matthews C, Niblock R, Dobbin E, Morris TC, Alexander HD (2006) ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia. Eur J Haemato 76(4):294–298 - DOI - PubMed
    1. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O’Brien S et al (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87(12):4990–4997 - PubMed

Publication types

MeSH terms

LinkOut - more resources